European Journal of Nuclear Medicine and Molecular Imaging

The European Journal of Nuclear Medicine and Molecular Imaging (EJNMMI) is a peer-reviewed medical journal published by Springer. It was the official journal of the European Association of Nuclear Medicine until December 2024.^[1] Since 1976, the EJNMMI has published material related to the field of nuclear medicine, including dosimetry, radiation biology, radiochemistry, radiopharmacology, molecular imaging probes, reporter gene assays, cell trafficking, targeting of endogenous gene expression, and antisense methodologies. As of 2021, the EJNMMI has an impact factor of 10.057.^[2]

European Journal of Nuclear Medicine and Molecular Imaging

Discipline	Nuclear Medicine
Language	English
Edited by	Arturo Chiti
Publication details
History	1976-present
Publisher	Springer Science+Business Media
Frequency	Monthly
Impact factor	9.236 (2020)
Standard abbreviations ISO 4 (alt) · Bluebook (alt) NLM (alt) · MathSciNet (alt )
ISO 4	Eur. J. Nucl. Med. Mol. Imaging
Indexing CODEN (alt · alt2) · JSTOR (alt) · LCCN (alt) MIAR · NLM (alt) · Scopus · W&L
CODEN	EJNMA6
ISSN	1619-7070 (print) 1619-7089 (web)
LCCN	2002252212
OCLC no.	49348061
Links
Journal homepage

Spin off

In summer of 2011, Springer launched EJNMMI Research, a peer-reviewed open access journal, as a companion to the EJNMMI. It accommodates articles that could not be published in EJNMMI.